Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The following are guidelines for evaluation and consideration for treatment of patients with inflammatory bone disease (IBD) after bone mineral density (BMD) measurements. The Crohn's & Colitis Foundation of America (CCFA) has indicated that its recommendations are intended to serve as reference points for clinical decision-making, not as rigid standards, limits, or rules. They should not be interpreted as quality standards.

Original publication

DOI

10.1097/00054725-200608000-00016

Type

Journal article

Journal

Inflammatory bowel diseases

Publication Date

08/2006

Volume

12

Pages

797 - 813

Addresses

University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania, Gastroenterology Division, Department of Medicine, Philadelphia, PA 19104-4283, USA. grl@uphs.upenn.edu

Keywords

Humans, Bone Diseases, Metabolic, Osteoporosis, Inflammatory Bowel Diseases, Fractures, Spontaneous, Calcium, Dietary, Vitamin D, Glucocorticoids, Absorptiometry, Photon, Risk Factors, Bone Remodeling, Bone Density, Bone Density Conservation Agents